
Massive cancer genome study reveals how DNA errors drive tumor growth
The largest ever study to analyze entire tumor genomes has provided…

Hereditary Breast Cancer Testing: New Recommendations
0 Comments
/
Earlier this year, the American Society of Breast Surgeons…

An update to tumor testing coverage for Medicare patients
Earlier this month, the Centers for Medicare and Medicaid…

Vitrakvi approved for NTRK+ cancers | MyOncoPath
FDA approves Vitrakvi in all tumor types with NTRK gene variants
Progress…

CNN Article: Breast cancer testing guidelines are out of date, missing genetic screening
Link to article: https://amp.cnn.com/cnn/2018/12/10/health/breast-cancer-genetic-testing-study
As…

FDA Finalizes Next Generation Sequencing Genetic Tests to Accelerate Reliable Development
FDA finalizes guidances to accelerate the development of reliable,…

FoundationOne CDx Comprehensive Genomic Profiling for Solid Tumors Now Commercially Available
Foundation Medicine Announces Commercial Availability of FoundationOne…

Precision Medicine, Genetic Testing & Targeted Therapies are Expanding Oncology Treatment Opportunities
This is an in depth review of the American Society of Clinical…

FDA approves first treatment for breast cancer with a certain inherited genetic mutation
The U.S. Food and Drug Administration today expanded the approved…

FDA announces approval, CMS proposes coverage of first breakthrough-designated test to detect extensive number of cancer biomarkers

